The Social Organization of Opioid Use for Chronic Pain
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
This dissertation is an institutional ethnography of the social organization of opioid use for chronic pain management in Ontario, Canada. Within the context of the contemporary ‘opioid crisis,’ people with chronic pain have found their access to prescription opioids restricted as physicians rapidly taper patients’ doses, adopt ‘no narcotics policies,’ and bar people with chronic pain who use opioids from their practices. These changes in physicians’ work of prescribing opioids have had significant impacts on the lives of people with chronic pain.
To explicate these abrupt changes in patients’ access to opioids, I conducted interviews with people with chronic pain and with health care practitioners, as well as analyses of texts including prescribing guidelines. I found that physicians have changed their opioid prescribing practices since the late aughts as the medical profession has come to be targeted as responsible for increases in opioid-related harms in North America. While previous panics around drug use targeted people who use drugs and attempted to change their behaviour, recent shifts in medico-legal conceptions of opioids have meant that opioid users have emerged in the public imaginary as blameless victims of unscrupulous physicians. Strategies to resolve the ‘epidemic’ of opioid-related harms have focused on changing physicians’ prescribing practices through new forms of opioid pharmacovigilance, surveillance, and punishment.
In response to these modes of surveillance and punishment, physicians have responded by adopting work practices that demonstrate their compliance with and accountability to these regimes of ruling. These include tapering patients’ doses and refusing to prescribe opioids to any patients ‘tainted’ by social determinants of health such as poverty or racialization. While people with chronic pain are not directly targeted by interventions to end the opioid crisis, they are impacted by these policies as physicians change their opioid prescribing practices in response to heightened surveillance and risk of penalties such as losing their license to practice or public shaming.